Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.34 |
| ▸ | CPB2 | Q96IY4 | 3/20 | 0.33 |
| ▸ | CPB1 | P15086 | 1/20 | 0.33 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.31 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.31 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5155910 | 0.99 | GSR (0.33) | GSRCPB2CPB1SLC15A2ITGB3 | |
| SCHEMBL3948451 | 0.92 | GSR (0.37) | GSRCPB2CPB1SLC15A2ITGB3 | |
| SCHEMBL5884482 | 0.91 | GSR (0.38) | GSRCPB2CPB1SLC15A2ITGB3 | |
| SCHEMBL15023743 | 0.91 | GSR (0.35) | GSRCPB2CPB1 | |
| SCHEMBL5598612 | 0.89 | GSR (0.34) | GSRCPB2CPB1ITGB3ITGA2B | |
| SCHEMBL5598853 | 0.89 | GSR (0.31) | GSRCPB2CPB1 | |
| SCHEMBL11028922 | 0.89 | CYP1A2 (0.32) | — | |
| SCHEMBL1959818 | 0.88 | CPB2 (0.33) | GSRCPB2CPB1ITGB3ITGA2B | |
| SCHEMBL8781595 | 0.88 | CPB2 (0.33) | GSRCPB2CPB1 | |
| SCHEMBL29271692 | 0.87 | ALOX15 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 361 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026040002-A1 | COMPOSITION AND METHOD FOR CARING FOR THE SKIN | L'OREAL (FR) | 2026-02-26 | — | — | WO | claimed |
| CN-116919846-A | Stem cell cytokine-containing composition and application thereof | 国源细胞工程有限责任公司 | 2023-10-24 | — | — | CN | claimed |
| US-10905744-B2 | Pharmaceutical formulations for the oral delivery of peptide drugs | CYPRUMED GMBH (AT) | 2021-02-02 | — | — | US | claimed |
| US-20180280481-A1 | PHARMACEUTICAL FORMULATIONS FOR THE ORAL DELIVERY OF PEPTIDE DRUGS | CYPRUMED GMBH (AT) | 2018-10-04 | — | — | US | claimed |
| CN-108135962-A | For the pharmaceutical preparation of oral delivery peptide medicament | 塞浦路迈德有限责任公司 | 2018-06-08 | — | — | CN | claimed |
| WO-2017060500-A1 | PHARMACEUTICAL FORMULATIONS FOR THE ORAL DELIVERY OF PEPTIDE DRUGS | CYPRUMED GMBH (AT) | 2017-04-13 | — | — | WO | claimed |
| EP-2059230-B1 | TOPICAL USE OF A PEPTIDE EXTRACT OF SOYBEAN AND/OR OF WHEAT AS PHOTOPROTECTIVE AGENT | THOREL JEAN-NOëL (FR) | 2016-11-30 | — | — | EP | claimed |
| US-8865857-B2 | Medical device with predefined activated cellular integration | SOFRADIM PRODUCTION (FR) | 2014-10-21 | — | — | US | claimed |
| EP-1594962-B1 | COVALENT TETHERING OF FUNCTIONAL GROUPS TO PROTEINS | PROMEGA CORP (US) | 2014-08-27 | — | — | EP | claimed |
| EP-2369006-B1 | Covalent tethering of functional groups to proteins | PROMEGA CORP (US) | 2014-03-12 | — | — | EP | claimed |
| US-20070031516-A1 | Composition for the prevention and treatment of cellulitis | LIPOTEC, S.A. (ES) | 2007-02-08 | — | — | US | claimed |
| CN-1767846-A | Composition for preventing and treating cellulitis | LIPOTEC SA (ES) | 2006-05-03 | — | — | CN | claimed |
| JP-2006504448-A | — | — | 2006-02-09 | — | — | JP | claimed |
| EP-1618125-A1 | VITAMIN C DERIVATIVES WITH PEPTIDE, PREPARATION METHOD THEREOF AND COMPOSITION COMPRISING THE SAME | Petron Co., Ltd. (KR) | 2006-01-25 | — | — | EP | claimed |
| EP-1611898-A1 | COMPOSITION FOR THE PREVENTION AND TREATMENT OF CELLULITIS | LIPOTEC, S.A. (ES) | 2006-01-04 | — | — | EP | claimed |
| EP-1534215-A1 | COMPOSITIONS CONTAINING PEPTIDE COPPER COMPLEXES AND SOFT TISSUE FILLERS | PROCYTE CORPORATION (US) | 2005-06-01 | — | — | EP | claimed |
| WO-2004096837-A1 | VITAMIN C DERIVATIVES WITH PEPTIDE, PREPARATION METHOD THEREOF AND COMPOSITION COMPRISING THE SAME | PEPTRON CO., LTD (KR) | 2004-11-11 | — | — | WO | claimed |
| WO-2004004671-A1 | COMPOSITIONS CONTAINING PEPTIDE COPPER COMPLEXES AND SOFT TISSUE FILLERS | PROCYTE CORPORATION (US) | 2004-01-15 | — | — | WO | claimed |
| WO-1994018230-A1 | INHIBITION OF HIV REPLICATION BY PEPTIDE-COPPER COMPLEXES | PROCYTE CORPORATION (US) | 1994-08-18 | — | — | WO | claimed |
| US-4732155-A | Implantable chemoattractant system | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 1988-03-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180280481-A1 | PHARMACEUTICAL FORMULATIONS FOR THE ORAL DELIVERY OF PEPTIDE DRUGS | SLC30A5, SLC39A11, SLC30A6 | GSR 3160/4885CPB2 2279/4885CPB1 1572/4885 |
| US-20070031516-A1 | Composition for the prevention and treatment of cellulitis | CUTA, LCT, LIPA | GSR 1538/4885CPB2 2112/4885CPB1 2946/4885 |
| US-10905744-B2 | Pharmaceutical formulations for the oral delivery of peptide drugs | SLC30A5, SLC39A11, SLC30A6 | GSR 3160/4885CPB2 2279/4885CPB1 1572/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.